In this report, global Chemotherapy Devices Market will reach 201.00 Million USD by the end of 2022 with a CAGR of 5.64%
The global Chemotherapy Devices market was valued at 152.80 Million USD in 2017 and will reach 201.00 Million USD by the end of 2022, growing at a CAGR of 5.64% during 2017-2022.
Chemotherapy pumps are one of the ways patients can have their chemotherapy. It allows patients to have chemo in a controlled way. Chemotherapy pumps are also called infusion pumps. Chemotherapy pumps may be capable of delivering fluids in large or small amounts, and may be used to deliver chemotherapy drugs.
Chemotherapy Devices can be divided into three categories: LVP type, Syringe Pump type and Elastomeric Pumps type. Syringe Pump type accounted for the highest proportion in sales market, with a figure of 36.08% in 2017, followed by LVP type, account for 32.17% and Elastomeric Pumps type account for 31.75%.
The sales market share of global Chemotherapy Devices in Hospital & Clinic use and Home Care use have been stable year by year, at 84.05% and 15.95% respectively in 2017, and for several consecutive years, the amplitude was within one percent. This indicates that the segment of the Chemotherapy Devices in the global market tends to be fixed without great changes. Among them, the Chemotherapy Devices market has the more promising sales prospects in Hospital & Clinic use.
XYZ research center data shows that North America is the biggest contributor to the Chemotherapy Devices revenue market, accounted for 41.27% of the total global market with a revenue of 63.06 million USD in 2017, followed by Europe, 39.07% with a revenue of 59.71 million USD.
Becton, Dickinson is the largest company in the global Chemotherapy Devices market, accounted for 16.50% of the revenue market share in 2017, followed by ICU Medical and Terumo Corporation
, accounted for 12.63% and 11.81% of the revenue market share in 2017. The Chemotherapy Devices industry is not concentrated, these manufacturers range from large multinational corporations to small privately owned companies compete in this industry. The top ten manufacturers account for 82.72% of the revenue market.
Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Chemotherapy Devices for these regions, from 2014 to 2026 (forecast), covering
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
Global Chemotherapy Devices market competition by top manufacturers/players, with Chemotherapy Devices sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
Becton, Dickinson
ICU Medical
Terumo Corporation
B. Braun
Halyard Health
Smiths Group
Baxter International
Fresenius
Moog
Zyno Medical
Micrel Medical
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
LVP (Large Volume Pump)
Syringe Pump
Elastomeric Pumps
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Chemotherapy Devices for each application, including
Hospital & Clinic
Home Care
If you have any special requirements, please let us know and we will offer you the report as you want.
Summary:
Get latest Market Research Reports on Chemotherapy Devices Sales. Industry analysis & Market Report on Chemotherapy Devices Sales is a syndicated market report, published as Global Chemotherapy Devices Sales Market(Sales,Revenue and competitors Analysis of Major Market)from 2014-2026. It is complete Research Study and Industry Analysis of Chemotherapy Devices Sales market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.